Search Results 161-170 of 3457 for Solid

  1. A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations - Mayo Clinic

    A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations · Overview · Participation eligibility.

  2. Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation - Mayo Clinic

    ... solid tumors, and to evaluate the pharmacokinetics (PK) of MRTX1133. Participation eligibility. Participant eligibility includes age, gender, type and stage ...

  3. A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid Tumors that cannot be Removed by Surgery - Mayo Clinic

    A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid ...

  4. Linezolid (oral route) - Side effects & dosage - Mayo Clinic

    Linezolid is used to treat certain bacterial infections in many different parts of the body, including certain types of skin infections or pneumonia. Linezolid ...

  5. A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors - Mayo Clinic

    A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors ... solid tumors and to identify a recommended Phase 2 dose for evaluation ...

  6. Professional Development - Curriculum - PGY-2 Pharmacy Residency in Solid Organ Transplant (AZ) - Mayo Clinic College of Medicine & Science

    PGY-2 Pharmacy Residency in Solid Organ Transplant at Mayo Clinic Hospital — Arizona Professional Development. Overview · Application Process · Curriculum.

  7. (VIDEO) Transplant Center at Mayo Clinic in Arizona sets a five-year national record for solid organ transplants

    Mayo Clinic in Arizona sets a five-year national record with 917 solid organ transplants in 2025. Learn more.

  8. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors - Mayo Clinic

    ... solid tumors including: Cohort A: Colorectal cancer (CRC);; Cohort B: Gastric and gastroesophageal junction (GEJ) cancer;; Cohort C: Triple-negative breast ...

  9. A Study to Evaluate MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation - Mayo Clinic

    The purpose of this study is to characterize the safety and tolerability of MRTX849 in patients having advanced solid tumor malignancies with KRAS G12C mutation ...

  10. Mayo Clinic Reports Solid 2012 Financial Performance

    ROCHESTER, Minn. — Mayo Clinic today reported a solid 2012 financial performance as it works to provide high-quality care at lower cost, strengthen its ...